Wilson H. Miller

2 ta ish

Huntsman Cancer Institute

1. Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma

   Robert H.I. Andtbacka, Howard L. Kaufman, Frances A. Collichio +26

   Maqola20153 iqtibos

   ABIABI:AkademIndex/2026.other.047644

2. RIG-I Is Required for the Inhibition of Measles Virus by Retinoids

   Kaitlin J. Soye, Claire Trottier, Chris Richardson +2

   Maqola20112 iqtibos

   ABIABI:AkademIndex/2026.other.637754